Table 3.
Multiple regression analysis showing the effect of various glycaemia and endothelial dysfunction markers on 2,3-Dinor-8-Iso-prostaglandin-F1α.
| Variable | Model | R 2 | β** | 95% CI | P value |
|---|---|---|---|---|---|
| HbA1c, % | Unadjusted | 0.027 | 1.07 | 1.01, 1.13 | 0.019 |
| Adjusted for covariates | 0.124 | 1.08 | 1.02, 1.14 | 0.009 | |
| 2 hr Glucose, mmol/L | Unadjusted | 0.016 | 1.02 | 1.00, 1.03 | 0.074 |
| Adjusted for covariates | 0.112 | 1.02 | 1.00, 1.04 | 0.052 | |
| Fasting blood glucose, mmol/L | Unadjusted | 0.028 | 1.04 | 1.01, 1.08 | 0.018 |
| Adjusted for covariates | 0.141 | 1.06 | 1.02, 1.10 | 0.002 | |
| ICAM, ng/mL | Unadjusted | 0.018 | 1.01 | 0.99, 1.03 | 0.183 |
| Adjusted for covariates | 0.118 | 1.01 | 0.99, 1.03 | 0.297 |
*Adjusted for age, gender, ethnicity, medication use, smoking status, and weight. Only results for variable of interest and ethnicity are shown.
**Regression coefficients were estimated using log-transformed PGF and back-transformed values are reported.